共 69 条
- [1] Friedlander A., Addeo A., Russo A., Et al., Targeted therapies in early stage NSCLC: type or hope?, Int J Mol Sci, 21, 17, (2020)
- [2] Bray F., Laversanne M., Sung H., Et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 74, 3, pp. 229-263, (2024)
- [3] David E.A., Clark J.M., Cooke D.T., Et al., The role of thoracic surgery in the therapeutic management of metastatic non-small cell lung cancer, J Thorac Oncol, 12, 11, pp. 1636-1645, (2017)
- [4] Darmadi D., Chugaeva U.Y., Saleh R.O., Et al., Critical roles of long noncoding RNA H19 in cancer, Cell Biochem Funct, 42, 3, (2024)
- [5] Zhao Z., Li H., Li J., Et al., Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression, J Cardiothorac Surg, 19, 1, (2024)
- [6] Ramezani M., Shamsabadi F.T., Shahbazi M., Harnessing the TP53INP1/TP53I3 axis for inhibition of colorectal cancer cell proliferation through MEG3 and Linc-ROR Co-expression, Heliyon, 10, 14, (2024)
- [7] Xu H., Ma H., Zha L., Et al., Engineered exosomes transporting the lncRNA, SVIL-AS1, inhibit the progression of lung cancer via targeting miR-21-5p, Am J Cancer Res, 14, 7, pp. 3335-3347, (2024)
- [8] Chen Z., Guan D., Zhu Q., Et al., Biological roles and pathogenic mechanisms of LncRNA MIR4435-2HG in cancer: a comprehensive review, Curr Issues Mol Biol, 45, 11, pp. 8864-8881, (2023)
- [9] Torres-Llanos Y., Zabaleta J., Cruz-Rodriguez N., Et al., MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL, Front Mol Biosci, 11, (2024)
- [10] Zhu R., Zhou H., Chen W., Et al., BCL2L1 is regulated by the lncRNA MIR4435-2HG-miR-513a-5p-BCL2L1 ceRNA axis and serves as a biomarker for pancreatic adenocarcinoma treatment and prognosis, Gene, 925, (2024)